Table 5.
Multiple Logistic Regression Analysis Predicting Nausea Group Membership (n = 1035)
Predictor | Odds Ratio | 95% CI | p-value |
---|---|---|---|
Education (years) | 0.93 | 0.89, 0.98 | 0.003 |
Child care responsibilities | 1.42 | 1.03, 1.97 | 0.032 |
Karnofsky Performance Status score | 0.96 | 0.95, 0.98 | < 0.001 |
CES-D score | 1.03 | 1.00,1.05 | 0.026 |
General Sleep Disturbance Scale score | 1.01 | 1.00,1.02 | 0.011 |
Evening fatigue score (LFS) | 1.12 | 1.04,1.20 | 0.003 |
Perceived Stress Scale score | 0.97 | 0.95, 0.99 | 0.015 |
IES-R Intrusion subscale score | 1.35 | 1.04, 1.75 | 0.026 |
CTX cycle length | 0.001 | ||
21 day cycle vs 14 day cycle | 0.58 | 0.44, 0.77 | < 0.001 |
28 day cycle vs 14 day cycle | 0.91 | 0.52, 1.61 | 0.754 |
21 day cycle vs 28 day cycle | 0.64 | 0.37, 1.11 | 0.110 |
Antiemetic regimen | 0.019 | ||
Steroid alone or serotonin receptor antagonist alone vs None | 0.88 | 0.48, 1.61 | 0.675 |
Serotonin receptor antagonist and steroid vs None | 1.52 | 0.87, 2.67 | 0.141 |
NK-1 receptor antagonist and two other antiemetics vs None | 1.37 | 0.75, 2.49 | 0.307 |
Serotonin receptor antagonist and steroid vs Steroid alone or serotonin receptor antagonist alone | 1.73 | 1.21, 2.49 | 0.003 |
Steroid alone or serotonin receptor antagonist alone vs NK-1 receptor antagonist and two other antiemetics | 0.64 | 0.42, 0.97 | 0.037 |
Serotonin receptor antagonist and steroid vs NK-1 receptor antagonist and two other antiemetics | 1.12 | 0.80, 1.56 | 0.529 |
Overall model fit: df = 13, X2 = 189.99, p < 0.001 |
Abbreviations: CES-D = Center for Epidemiological Studies-Depression Scale, CI = confidence interval, CTX = chemotherapy, IES-R = Impact of Event Scale-Revised, LFS = Lee Fatigue Scale, NK-1 = neurokinin-1